Inspire Medical Systems, Inc. INSP
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 898.74M | 915.25M | 911.98M | 882.62M | 861.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 898.74M | 915.25M | 911.98M | 882.62M | 861.31M |
| Cost of Revenue | 124.64M | 130.19M | 133.23M | 133.14M | 133.77M |
| Gross Profit | 774.11M | 785.06M | 778.76M | 749.48M | 727.55M |
| SG&A Expenses | 620.31M | 632.55M | 624.64M | 604.19M | 575.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 844.62M | 863.93M | 861.03M | 845.90M | 819.91M |
| Operating Income | 54.12M | 51.32M | 50.95M | 36.73M | 41.40M |
| Income Before Tax | 69.38M | 63.94M | 65.70M | 52.01M | 58.79M |
| Income Tax Expenses | -65.66M | -67.20M | -79.73M | 7.46M | 5.67M |
| Earnings from Continuing Operations | 135.04 | 131.14 | 145.42 | 44.56 | 53.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 135.04M | 131.14M | 145.42M | 44.56M | 53.12M |
| EBIT | 54.12M | 51.32M | 50.95M | 36.73M | 41.40M |
| EBITDA | 71.33M | 67.34M | 64.91M | 49.34M | 52.19M |
| EPS Basic | 4.66 | 4.53 | 5.02 | 1.50 | 1.78 |
| Normalized Basic EPS | 1.49 | 1.46 | 1.50 | 1.27 | 1.32 |
| EPS Diluted | 4.62 | 4.49 | 4.98 | 1.46 | 1.72 |
| Normalized Diluted EPS | 1.48 | 1.45 | 1.48 | 1.24 | 1.28 |
| Average Basic Shares Outstanding | 115.81M | 116.48M | 117.48M | 118.37M | 118.92M |
| Average Diluted Shares Outstanding | 116.46M | 117.03M | 118.64M | 120.17M | 121.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |